NO159394C - Fremgangsmaate for fremstilling av immunogene kapselformede polyosider fra kapselbakterier. - Google Patents
Fremgangsmaate for fremstilling av immunogene kapselformede polyosider fra kapselbakterier.Info
- Publication number
- NO159394C NO159394C NO822592A NO822592A NO159394C NO 159394 C NO159394 C NO 159394C NO 822592 A NO822592 A NO 822592A NO 822592 A NO822592 A NO 822592A NO 159394 C NO159394 C NO 159394C
- Authority
- NO
- Norway
- Prior art keywords
- polyosides
- capsular
- capsulated
- bacteriae
- give
- Prior art date
Links
- 230000002163 immunogen Effects 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 241000894006 Bacteria Species 0.000 title 1
- 239000002775 capsule Substances 0.000 title 1
- 239000000463 material Substances 0.000 abstract 6
- 230000000813 microbial effect Effects 0.000 abstract 4
- 230000000717 retained effect Effects 0.000 abstract 4
- 238000001914 filtration Methods 0.000 abstract 2
- 150000002632 lipids Chemical class 0.000 abstract 2
- 239000007791 liquid phase Substances 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 239000012528 membrane Substances 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0266—Klebsiella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Polyesters Or Polycarbonates (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8114842A FR2510606A1 (fr) | 1981-07-30 | 1981-07-30 | Procede d'obtention de polyosides capsulaires, polyosides capsulaires ainsi obtenus et leur application a la preparation de vaccins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO822592L NO822592L (no) | 1983-01-31 |
| NO159394B NO159394B (no) | 1988-09-12 |
| NO159394C true NO159394C (no) | 1988-12-21 |
Family
ID=9261011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO822592A NO159394C (no) | 1981-07-30 | 1982-07-28 | Fremgangsmaate for fremstilling av immunogene kapselformede polyosider fra kapselbakterier. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0071515B1 (OSRAM) |
| AT (1) | ATE16244T1 (OSRAM) |
| CA (1) | CA1206905A (OSRAM) |
| DD (1) | DD202623A5 (OSRAM) |
| DE (1) | DE3267160D1 (OSRAM) |
| DK (1) | DK327182A (OSRAM) |
| ES (1) | ES514496A0 (OSRAM) |
| FR (1) | FR2510606A1 (OSRAM) |
| IE (1) | IE53582B1 (OSRAM) |
| NO (1) | NO159394C (OSRAM) |
| PT (1) | PT75301B (OSRAM) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3683844D1 (de) * | 1986-03-27 | 1992-03-19 | Schweiz Serum & Impfinst | Impfstoff des klebsiella kapsulpolysaccharids. |
| US6426074B1 (en) * | 1997-03-19 | 2002-07-30 | The Brigham And Women's Hospital Inc. | Group B Streptococcus vaccine |
| EP1967591A3 (en) * | 2000-03-16 | 2008-12-03 | The Children's Hospital Of Philadelphia | Method of assessing the usefulness of a test compound for alleviating a pneumococcal infection in an animal |
| NZ511680A (en) | 2001-05-14 | 2004-07-30 | Univ Waikato | Method for preparing nucleic acid or DNA samples and a DNA extraction process using thermophilic proteases |
| GB0522303D0 (en) * | 2005-11-01 | 2005-12-07 | Chiron Srl | Culture method |
| WO2008129559A2 (en) | 2007-04-23 | 2008-10-30 | Serum Institute Of India Ltd | Antigenic polysaccharides and process for their preparation |
| WO2011148382A1 (en) | 2010-05-28 | 2011-12-01 | Biological E Limited | An improved process for the purification of capsular polysaccharides of haemophilus influenza - b, neisseria meningitis such as serotypes a, c, y and w-135, and other similar related capsular polysaccharides produced from both gram negative and gram positive microorganisms using aluminium phosphate with alcohol. |
| WO2011151841A1 (en) * | 2010-05-31 | 2011-12-08 | Panacea Biotec Limited | Fermentation process for streptococcus pneumoniae |
| US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
| MX2019007910A (es) | 2016-12-30 | 2019-12-05 | Sutrovax Inc | Conjugados de polipeptido-antigeno con aminoacidos no naturales. |
| WO2020010016A1 (en) | 2018-07-04 | 2020-01-09 | Sutrovax, Inc. | Self-adjuvanted immunogenic conjugates |
| CN120202227A (zh) | 2022-09-19 | 2025-06-24 | 生物学E有限公司 | 纯化荚膜多糖的方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2166963A (en) * | 1936-11-19 | 1939-07-25 | Sharp & Dohme Inc | Antigenic polysaccharide complex |
| US2528972A (en) * | 1947-05-15 | 1950-11-07 | Western Reserve University | Prophylactic toxoid compound and method of making same |
| FR2407262A1 (fr) * | 1977-10-27 | 1979-05-25 | Cassenne Lab Sa | Nouveaux polysaccharides extraits de corps microbiens d'haemophilus influenzae, procede de preparation et application a titre de medicaments de ces nouveaux produits |
| CA1115210A (en) * | 1977-11-28 | 1981-12-29 | Dennis J. Carlo | Pneumococcal vaccine |
| US4264764A (en) * | 1979-01-12 | 1981-04-28 | Merck & Co., Inc. | Meningitis vaccine |
| US4221906A (en) * | 1979-03-19 | 1980-09-09 | American Cyanamid Company | Stabilization of pneumococcal polysaccharides |
| US4307080A (en) * | 1979-09-24 | 1981-12-22 | Merck & Co., Inc. | Meningitis vaccine |
| US4287173A (en) * | 1979-09-24 | 1981-09-01 | Merck & Co., Inc. | Vaccine for dental caries |
-
1981
- 1981-07-30 FR FR8114842A patent/FR2510606A1/fr active Granted
-
1982
- 1982-07-15 IE IE1705/82A patent/IE53582B1/en unknown
- 1982-07-19 AT AT82401343T patent/ATE16244T1/de not_active IP Right Cessation
- 1982-07-19 DE DE8282401343T patent/DE3267160D1/de not_active Expired
- 1982-07-19 EP EP82401343A patent/EP0071515B1/fr not_active Expired
- 1982-07-21 DK DK327182A patent/DK327182A/da not_active Application Discontinuation
- 1982-07-23 PT PT75301A patent/PT75301B/pt not_active IP Right Cessation
- 1982-07-28 NO NO822592A patent/NO159394C/no unknown
- 1982-07-28 CA CA000408233A patent/CA1206905A/en not_active Expired
- 1982-07-29 DD DD82242065A patent/DD202623A5/de unknown
- 1982-07-29 ES ES514496A patent/ES514496A0/es active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| PT75301A (fr) | 1982-08-01 |
| DD202623A5 (de) | 1983-09-28 |
| EP0071515A1 (fr) | 1983-02-09 |
| DE3267160D1 (en) | 1985-12-05 |
| ATE16244T1 (de) | 1985-11-15 |
| NO159394B (no) | 1988-09-12 |
| EP0071515B1 (fr) | 1985-10-30 |
| ES8305827A1 (es) | 1983-04-16 |
| IE821705L (en) | 1983-01-30 |
| NO822592L (no) | 1983-01-31 |
| FR2510606B1 (OSRAM) | 1984-10-26 |
| ES514496A0 (es) | 1983-04-16 |
| FR2510606A1 (fr) | 1983-02-04 |
| PT75301B (fr) | 1984-07-31 |
| IE53582B1 (en) | 1988-12-21 |
| DK327182A (da) | 1983-01-31 |
| CA1206905A (en) | 1986-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO159394C (no) | Fremgangsmaate for fremstilling av immunogene kapselformede polyosider fra kapselbakterier. | |
| DE3784860D1 (de) | Verbessertes verfahren zur transformation von pflanzlichen protoplasten. | |
| DE3681811D1 (de) | Verfahren zur kontinuierlichen herstellung von l-carnitin. | |
| NO875319D0 (no) | Fremgangsmaate for ekstracellulaer fremstilling av homopolysakkarider. | |
| EP0067697B1 (en) | Cell culture method | |
| FR2545099B1 (fr) | Nouvelle souche de trichoderma harzianum procede d'isolement de cette souche, procede de culture de cette souche, nouveaux peptides produits par cette souche, et application de cette souche et ces nouveaux peptides ou du produit obtenu par le procede de culture comme moyen de lutte biologique sous forme de produit phytosanitaire | |
| ATE9100T1 (de) | Trichosporon kashiwayama ifo 1964, kulturbruehe, zell-freie sterile fluessigkeit, steriles filtrat, steriler ueberstand, steriles konzentrat und steriles trockenprodukt einer kulturbruehe, verfahren zur herstellung einer kulturbruehe, pharmazeutische zusammensetzung, kosmetische zusammensetzung. | |
| FR2338256A1 (fr) | Nouveaux esters aryloxy(thio)carbonylaminomethyliques d'acides phenoxycarboxyliques, leur procede de preparation et leur application comme substances de croissance des plantes | |
| ATE21033T1 (de) | Verfahren zur herstellung eines immunogens aus pasteurella multocida. | |
| JPS5658491A (en) | Immunoactivating substance ies-1638 having antitumor activity, and its preparation | |
| JPS5675095A (en) | Preparation of heat-resistant acetic acid kinase | |
| RU93028311A (ru) | Способ получения биологически активных веществ из биомассы культивируемых клеток растений | |
| JPS55102389A (en) | Novel microorganism | |
| JPS5682095A (en) | Purification of fatty acid produced through fermentation process | |
| SU854978A1 (ru) | Способ очистки молокосвертывающего фермента | |
| RU92008994A (ru) | Способ получения тромбоцитов | |
| ES8406543A1 (es) | Procedimiento para la produccion de un plastico hibrido. | |
| RU94025893A (ru) | Способ выделения биологически активных веществ | |
| DE68918269D1 (de) | Pflanzenvirusbekämpfungsmittel und verfahren zur herstellung. | |
| JPH0418006A (ja) | 天然ジャスミン酸の抽出分離方法 | |
| RU96105588A (ru) | Способ получения противоопухолевого средства | |
| JPS6483100A (en) | Production of animal cell growth factor | |
| JPS5675500A (en) | Dc-11-a-3 | |
| RU95117249A (ru) | Способ получения дифтерийного токсина | |
| JPS5687594A (en) | Antibiotic substance xk-209 and its preparation |